⌘K
Loading ticker…
As of 2026-08-26, Neogen Corp (NEOG) has a 3-month relative strength percentile of 86 and a leadership percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 66. The current market Stance is 50.1 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.7%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
NEOG is in a stage 2 uptrend, week 4. Currently in a 5-day base; basing ADR 3.6% (broad 4.1%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 12.9% / 27.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
NEOG is held by 32 ETFs as of May 2026. Top owner: VTWO at 0.06% weight, $10M notional. Top 3 carry $26M.
Held by 70 ETFs · $506M across latest filings · largest weight 1.64% (XHE).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.06% | $10M | −0.02 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.04% | $9M | −0.02 pp |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.11% | $7M | −0.04 pp |
| FNDA | 0.07% | $6M | −0.02 pp |
| VHTVanguard Health Care ETF | 0.03% |
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| $6M |
| — |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.23% | $4M | −0.09 pp |
| AVSC | 0.11% | $3M | — |
| NBSM | 1.11% | $3M | new |
| VTWV | 0.12% | $2M | −0.04 pp |
| PSCH | 1.04% | $1M | −0.41 pp |
Showing 10 of 32 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NEOG Jan avg: 14.56% median: 17.49% win: 50% σ: 34.11% n: 4 2022-04-12 → 2026-07-31 | NEOG Feb avg: -2.22% median: -1.21% win: 50% σ: 14.72% n: 4 2022-04-12 → 2026-07-31 | NEOG Mar avg: -8.63% median: -10.97% win: 25% σ: 9.63% n: 4 2022-04-12 → 2026-07-31 | NEOG Apr avg: -16.88% median: -14.95% win: 20% σ: 16.36% n: 5 2022-04-12 → 2026-07-31 | NEOG May avg: 3.98% median: 1.57% win: 80% σ: 7.84% n: 5 2022-04-12 → 2026-07-31 | NEOG Jun avg: 3.21% median: 0.22% win: 60% σ: 18.15% n: 5 2022-04-12 → 2026-07-31 | NEOG Jul avg: 8.56% median: 6.62% win: 60% σ: 15.26% n: 5 2022-04-12 → 2026-07-31 | NEOG Aug avg: 3.75% median: 0.50% win: 50% σ: 14.12% n: 4 2022-04-12 → 2026-07-31 (current) | NEOG Sep avg: -14.05% median: -11.18% win: 0% σ: 15.37% n: 4 2022-04-12 → 2026-07-31 | NEOG Oct avg: -8.05% median: -10.28% win: 25% σ: 12.25% n: 4 2022-04-12 → 2026-07-31 | NEOG Nov avg: 8.91% median: 6.63% win: 50% σ: 13.36% n: 4 2022-04-12 → 2026-07-31 | NEOG Dec avg: 3.24% median: 4.43% win: 50% σ: 16.90% n: 4 2022-04-12 → 2026-07-31 |